B-intervention	0	8	Exercise
I-intervention	9	12	and
I-intervention	13	20	dietary
I-intervention	21	27	advice
I-intervention	28	40	intervention
O	41	44	for
O	45	54	survivors
O	55	57	of
O	58	64	triple
O	64	65	-
O	65	73	negative
O	74	80	breast
O	81	87	cancer
O	87	88	:
O	89	96	effects
O	97	99	on
O	100	104	body
O	105	108	fat
O	108	109	,
O	110	118	physical
O	119	127	function
O	127	128	,
O	129	136	quality
O	137	139	of
O	140	144	life
O	144	145	,
O	146	149	and
O	150	159	adipokine
O	160	167	profile
O	167	168	.

O	169	176	Regular
O	177	185	exercise
O	186	189	and
O	190	197	healthy
O	198	204	eating
O	205	208	are
O	209	218	routinely
O	219	230	recommended
O	231	234	for
O	235	241	breast
O	242	248	cancer
O	249	258	survivors
O	258	259	,
O	260	263	and
O	264	268	past
O	269	276	studies
O	277	281	show
O	282	290	benefits
O	291	293	in
O	294	301	quality
O	302	304	of
O	305	309	life
O	310	313	and
O	314	323	decreased
O	324	336	inflammation
O	336	337	.

O	338	345	However
O	345	346	,
O	347	351	this
O	352	355	has
O	356	359	not
O	360	364	been
O	365	371	tested
O	372	384	specifically
O	385	387	in
O	388	394	triple
O	394	395	-
O	395	403	negative
O	404	410	breast
O	411	417	cancer
O	418	427	survivors
O	427	428	.

O	429	439	Increasing
O	440	448	physical
O	449	457	activity
O	458	461	and
O	462	468	losing
O	469	473	body
O	474	477	fat
O	478	481	are
O	482	489	thought
O	490	492	to
O	493	503	positively
O	504	510	affect
O	511	523	inflammatory
O	524	534	biomarkers
O	535	539	that
O	540	544	have
O	545	549	been
O	550	560	associated
O	561	565	with
O	566	572	breast
O	573	579	cancer
O	579	580	.

O	581	590	Therefore
O	590	591	,
O	592	595	the
O	596	603	primary
O	604	611	purpose
O	612	614	of
O	615	619	this
O	620	625	study
O	626	629	was
O	630	632	to
O	633	642	determine
O	643	645	if
O	646	659	participation
O	660	662	in
O	663	665	an
O	666	674	exercise
O	675	678	and
O	679	686	dietary
O	687	697	counseling
O	698	705	program
O	706	709	can
O	710	717	improve
O	718	722	body
O	723	726	fat
O	726	727	,
O	728	736	physical
O	737	745	function
O	745	746	,
O	747	750	and
O	751	758	quality
O	759	761	of
O	762	766	life
O	767	769	in
O	770	779	survivors
O	780	782	of
O	783	787	this
O	788	798	aggressive
O	799	805	breast
O	806	812	cancer
O	812	813	.

O	814	825	Secondarily
O	825	826	,
O	827	829	we
O	830	836	sought
O	837	839	to
O	840	849	determine
O	850	852	if
O	853	866	participation
O	867	869	in
O	870	873	the
O	874	881	program
O	882	885	had
O	886	896	beneficial
O	897	904	effects
O	905	907	on
O	908	915	obesity
O	915	916	-
O	916	923	related
O	924	931	markers
O	932	934	of
O	935	938	the
O	939	948	adipokine
O	949	956	profile
O	956	957	.

B-total-participants	958	963	Sixty
I-total-participants	963	964	-
I-total-participants	964	967	six
B-eligibility	968	977	survivors
I-eligibility	978	980	of
I-eligibility	981	987	triple
I-eligibility	987	988	-
I-eligibility	988	996	negative
I-eligibility	997	1003	breast
I-eligibility	1004	1010	cancer
I-eligibility	1011	1015	with
I-eligibility	1016	1019	BMI
I-eligibility	1020	1021	>
I-eligibility	1021	1023	25
O	1024	1028	were
O	1029	1036	invited
O	1037	1039	to
O	1040	1051	participate
O	1051	1052	.

B-total-participants	1053	1059	Twenty
I-total-participants	1059	1060	-
I-total-participants	1060	1065	eight
O	1066	1074	enrolled
O	1075	1078	and
B-total-participants	1079	1081	23
O	1082	1091	completed
O	1092	1095	the
O	1096	1106	randomized
O	1106	1107	,
O	1108	1118	controlled
O	1119	1124	trial
O	1125	1126	(
B-intervention-participants	1126	1128	13
O	1129	1141	intervention
O	1141	1142	,
B-control-participants	1143	1145	10
B-control	1146	1153	control
O	1153	1154	)
O	1154	1155	.

O	1156	1164	Moderate
O	1164	1165	-
O	1165	1174	intensity
O	1175	1182	aerobic
O	1183	1191	exercise
O	1192	1193	(
O	1193	1196	150
O	1197	1200	min
O	1201	1204	per
O	1205	1209	week
O	1209	1210	,
O	1211	1214	for
O	1215	1217	12
O	1218	1223	weeks
O	1223	1224	)
O	1225	1228	and
O	1229	1233	diet
O	1234	1244	counseling
O	1245	1249	were
O	1250	1258	compared
O	1259	1261	to
O	1262	1267	usual
O	1268	1272	care
O	1272	1273	,
O	1274	1283	education
O	1284	1288	only
O	1288	1289	.

O	1290	1293	The
O	1294	1301	primary
O	1302	1309	outcome
O	1310	1312	of
O	1313	1321	interest
O	1322	1325	was
B-outcome-Measure	1326	1332	weight
I-outcome-Measure	1333	1337	loss
I-outcome-Measure	1338	1339	(
I-outcome-Measure	1339	1343	body
I-outcome-Measure	1344	1348	mass
I-outcome-Measure	1348	1349	,
I-outcome-Measure	1350	1353	BMI
I-outcome-Measure	1353	1354	,
I-outcome-Measure	1355	1356	%
I-outcome-Measure	1357	1360	fat
I-outcome-Measure	1360	1361	)
O	1361	1362	,
O	1363	1366	and
O	1367	1376	secondary
O	1377	1385	outcomes
O	1386	1394	included
B-outcome-Measure	1395	1403	physical
I-outcome-Measure	1404	1412	function
I-outcome-Measure	1413	1414	(
I-outcome-Measure	1414	1422	exercise
I-outcome-Measure	1423	1431	capacity
I-outcome-Measure	1431	1432	)
O	1432	1433	,
B-outcome-Measure	1434	1441	quality
I-outcome-Measure	1442	1444	of
I-outcome-Measure	1445	1449	life
O	1450	1451	(
O	1451	1459	Function
O	1460	1465	After
O	1466	1472	Cancer
O	1473	1480	Therapy
O	1480	1481	-
O	1481	1487	Breast
O	1488	1489	(
O	1489	1493	FACT
O	1493	1494	-
O	1494	1495	B
O	1495	1496	)
O	1496	1497	)
O	1497	1498	,
B-outcome-Measure	1499	1508	cytokines
O	1509	1510	(
O	1510	1511	C
O	1511	1512	-
O	1512	1520	reactive
O	1521	1528	protein
O	1529	1530	(
O	1530	1533	CRP
O	1533	1534	)
O	1534	1535	,
O	1536	1539	TNF
O	1539	1540	-
O	1540	1541	Î±
O	1541	1542	,
O	1543	1545	IL
O	1545	1546	-
O	1546	1547	6
O	1547	1548	)
O	1548	1549	,
O	1550	1553	and
B-outcome-Measure	1554	1563	adipokine
I-outcome-Measure	1564	1571	profile
O	1572	1573	(
O	1573	1579	leptin
O	1579	1580	,
O	1581	1592	adiponectin
O	1592	1593	,
O	1594	1601	insulin
O	1601	1602	)
O	1602	1603	.

O	1604	1616	Participants
O	1617	1619	in
O	1620	1623	the
O	1624	1631	program
B-outcome	1632	1636	lost
I-outcome	1637	1641	more
I-outcome	1642	1646	body
I-outcome	1647	1650	fat
O	1651	1652	(
O	1652	1653	2
O	1653	1654	.
O	1654	1655	4
O	1656	1657	%
O	1658	1662	loss
O	1663	1665	vs
O	1665	1666	.
O	1667	1668	0
O	1668	1669	.
O	1669	1670	4
O	1671	1672	%
O	1673	1677	gain
O	1677	1678	,
O	1679	1680	p
O	1681	1682	<
O	1683	1684	0
O	1684	1685	.
O	1685	1687	05
O	1687	1688	)
O	1689	1693	than
O	1694	1697	the
O	1698	1705	control
O	1706	1711	group
O	1711	1712	.

O	1713	1716	The
O	1717	1729	intervention
O	1730	1735	group
O	1736	1740	also
O	1741	1749	improved
B-outcome	1750	1757	quality
I-outcome	1758	1760	of
I-outcome	1761	1765	life
O	1766	1767	(
O	1767	1771	FACT
O	1771	1772	-
O	1772	1773	B
O	1774	1779	total
O	1780	1785	score
O	1786	1787	+
O	1787	1789	14
O	1790	1793	pts
O	1793	1794	)
O	1795	1798	and
O	1799	1808	decreased
B-outcome	1809	1818	sedentary
I-outcome	1819	1823	time
O	1824	1827	but
O	1828	1831	did
O	1832	1835	not
O	1836	1843	improve
B-outcome	1844	1848	peak
I-outcome	1849	1857	exercise
I-outcome	1858	1866	capacity
O	1866	1867	.

O	1868	1871	The
O	1872	1884	intervention
O	1885	1888	had
O	1889	1891	no
O	1892	1898	effect
O	1899	1901	on
B-outcome	1902	1907	serum
I-outcome	1908	1917	cytokines
I-outcome	1918	1921	and
I-outcome	1922	1932	adipokines
O	1933	1938	after
O	1939	1941	12
O	1942	1947	weeks
O	1948	1950	in
O	1951	1954	the
O	1955	1962	program
O	1962	1963	.

O	1964	1971	However
O	1971	1972	,
B-outcome	1973	1978	serum
I-outcome	1979	1985	leptin
I-outcome	1986	1989	and
I-outcome	1990	2001	adiponectin
O	2002	2005	and
O	2006	2011	their
O	2012	2017	ratio
O	2018	2022	were
O	2023	2036	significantly
O	2037	2047	correlated
O	2048	2052	with
O	2053	2056	BMI
O	2057	2059	in
O	2060	2063	the
O	2064	2076	intervention
O	2077	2082	group
O	2083	2084	(
O	2084	2085	p
O	2086	2087	<
O	2088	2089	0
O	2089	2090	.
O	2090	2092	05
O	2092	2093	)
O	2093	2094	.

O	2095	2103	Exercise
O	2104	2107	and
O	2108	2115	dietary
O	2116	2126	counseling
O	2127	2130	led
O	2131	2133	to
O	2134	2138	loss
O	2139	2141	of
O	2142	2146	body
O	2147	2150	fat
O	2151	2154	and
O	2155	2163	improved
O	2164	2171	quality
O	2172	2174	of
O	2175	2179	life
O	2180	2182	in
O	2183	2192	survivors
O	2193	2195	of
O	2196	2202	triple
O	2202	2203	-
O	2203	2211	negative
O	2212	2218	breast
O	2219	2225	cancer
O	2225	2226	.

O	2227	2230	BMI
O	2231	2234	was
O	2235	2245	associated
O	2246	2250	with
O	2251	2260	favorable
O	2261	2268	changes
O	2269	2271	in
O	2272	2278	leptin
O	2279	2282	and
O	2283	2294	adiponectin
O	2295	2300	which
O	2301	2304	may
O	2305	2312	reflect
O	2313	2314	a
O	2315	2321	change
O	2322	2324	in
O	2325	2334	adiposity
O	2335	2339	with
O	2340	2352	intervention
O	2352	2353	.

O	2354	2362	Exercise
O	2363	2366	and
O	2367	2374	healthy
O	2375	2381	eating
O	2382	2385	may
O	2386	2388	be
O	2389	2396	equally
O	2397	2406	effective
O	2407	2409	in
O	2410	2414	this
O	2415	2419	high
O	2419	2420	-
O	2420	2424	risk
O	2425	2435	population
O	2436	2438	as
O	2439	2441	in
O	2442	2447	other
O	2448	2454	breast
O	2455	2461	cancer
O	2462	2471	survivors
O	2472	2475	and
O	2476	2482	should
O	2483	2485	be
O	2486	2496	encouraged
O	2497	2499	as
O	2500	2501	a
O	2502	2506	part
O	2507	2509	of
O	2510	2511	a
O	2512	2518	cancer
O	2519	2531	survivorship
O	2532	2539	program
O	2539	2540	.
